Navigation Links
Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
Date:5/19/2008

- RDEA594 Data to Be Presented at the 2008 Annual European Congress of Rheumatology Organized by the European League Against Rheumatism (EULAR) - - Initiation of Phase 1 Human Study of RDEA594 Planned in Second Half of

2008 -

SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced the identification of its lead development candidate for the treatment of patients with gout, RDEA594. Gout is a painful and debilitating disease that is caused by abnormally elevated levels of uric acid in the blood stream. RDEA594 is a major metabolite in both humans and animals of RDEA806, the Company's lead human immunodeficiency virus (HIV) development candidate. RDEA594 does not have significant antiviral activity, but is believed to be responsible for essentially all of the uric acid lowering effects seen with RDEA806. Robust uric acid-lowering effects have been observed following administration of RDEA806 in Phase 1 and Phase 2 clinical trials that included over 100 subjects.

Based on extensive in vitro and in vivo experiments, the Company believes it has elucidated the mechanism by which RDEA594 lowers serum uric acid levels. RDEA594 exhibits a concentration-dependent inhibitory effect on the URAT1 transporter-mediated uptake of uric acid ex vivo and increases uric acid excretion in animal models. These effects are believed to result in the lowering of serum uric acid observed with RDEA806. URAT1 is a specific urate transporter expressed in the kidney responsible for regulation of uric acid levels, and is a validated target for treatment of hyperuricemia and gout.

"Gout represents a major medical challenge in the United States and throughout the world,
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
2. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
3. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
4. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
5. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
10. Neurocrine Biosciences Reports First Quarter 2008 Results
11. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a multivariate ... has appointed Holly B. Bauzon as Vice ... Bauzon has a proven track record in both increasing ... companies. She has more than 20 years of healthcare ... the position of Director, Lab Services Sales and Managed ...
(Date:8/21/2014)...  eRelevance Corporation ( www.erelevancecorp.com ), a progressive ... has completed integration with Nextech, a popular Electronic ... Dermatology practices. "Integration allows our service ... using Nextech," stated Bob Fabbio , co-founder ... the EMR we are able to automatically target ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014  Publicis ... Shannon Hartley , Managing Partner and Healthcare Industry ... of PharmaVoice 100, which recognizes the most inspiring people ... group are leaders in research and development, marketing, technology, ... the agency in 2006 as a partner in its ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2
... The AXA Research Fund closed out its first year ... than Euro 13 million to various European research institutions.The purpose ... of major risks in the world by supporting cutting edge ... Euro 100 million over five years, making it a major ...
... Research features from Mayo ClinicROCHESTER, Minn., March 23 ... of Discovery,s Edge, Mayo Clinic,s research magazine. You ... often as you wish. Reprinting is allowed with ... as your editorial policies permit: Visit http://discoverysedge.mayo.edu ...
Cached Medicine Technology:First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 2First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 3Discovery's Edge Spring Issue - http://discoverysedge.mayo.edu 2
(Date:8/22/2014)... August 22, 2014 FastFingerprints is adding ... The office will open Wednesday, August 27, 2014 and ... OH 44115. With the addition of this new ... FastFingerprints locations in the Cleveland area. Our new ... FBI background checks. The hours of operation will be ...
(Date:8/22/2014)... The rising numbers of teen drug and teen ... For many years, countless lives have been lost due to ... community a new helpline was established to provide a valuable ... who are seeking to overcome their addiction issues. , ... parents and their teens can speak immediately to a representative ...
(Date:8/22/2014)... 2014 Teen substance abuse has long ... Unfortunately, most young adults never receive the professional treatment ... community, the new Troubled Teens Columbus helpline was established ... overcome their drug and alcohol dependencies . ... and their parents can speak directly to a representative ...
(Date:8/22/2014)... 22, 2014 Drug and alcohol ... the years, substance abuse has claimed thousands of lives ... OH is providing hope for teenagers who are seeking ... helpline is designed to provide adolescents and their parents ... find the best youth rehab facility to meet their ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Dr Murray Grossan ... this snoring cure. , In the October 2014 issue of ... Dr Grossan about his method of treating snoring, and in ... Dr Grossan: "Nearly half of all adults snore occasionally, and ... This is because air passages in the back of the ...
Breaking Medicine News(10 mins):Health News:FastFingerprints Expands In The Cleveland Ohio Area 2Health News:FastFingerprints Expands In The Cleveland Ohio Area 3Health News:Troubled Teens in Asheville, NC Turn to Helpline for Valuable Assistance 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3
... studies find no clear link; other research supports fiber to ... -- An adult woman,s intake of meat, eggs and dairy ... research shows. , For years, dietary factors have been debated ... with research yielding conflicting results. But in the new research, ...
... , DETROIT, Aug. 28 WDIV-TV, ... launch The Biggest Loser: Detroit Edition contest on Monday, August 31. ... applicants to compete in this 12-week weight loss challenge to be ... is one of the most popular programs, and America,s Thanksgiving Parade ...
... absentee rate, research shows , FRIDAY, Aug. 28 (HealthDay ... work, employees take more sick days, a new study ... nearly 3,000 workers and found that absenteeism was higher ... interfering with work. These employees felt the demands they ...
... NEW YORK, Aug. 28 A serious breathing condition ... and helping to manage it could mean paying special attention ... Listen to this report from Boehringer Ingelheim Pharmaceuticals, Inc. & ... , Registered journalists can access video, audio, text, ...
... , , , , ... Inc. (NYSE: DVA ), a leading provider of kidney ... announced its nocturnal dialysis patient population has reached a milestone, with ... DaVita(R) centers around the nation. DaVita has one of the largest ...
... after, and protect liver from damage, experts say , FRIDAY, ... lots of water, get plenty of rest -- and eat ... the amino acids and minerals in asparagus extract may ease ... , Researchers at the Institute of Medical Science and Jeju ...
Cached Medicine News:Health News:Meat, Dairy Won't Up Odds for Breast Cancer 2Health News:Meat, Dairy Won't Up Odds for Breast Cancer 3Health News:WDIV-TV, Blue Cross Blue Shield of Michigan and The Parade Company Help Launch The Biggest Loser: Detroit Edition 2Health News:DaVita Offers Dialysis While Patients Sleep 2Health News:DaVita Offers Dialysis While Patients Sleep 3Health News:Asparagus May Ease Hangover 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: